Publication date: Jan 04, 2020
The research will examine whether CBD and other cannabinoids can relieve pain in patients with multiple sclerosis; if cannabis can reduce neuroinflammation and degeneration of the brain caused by Huntington’s disease; and if cannabinoids have neuroprotective activity in models of Alzheimer’s disease.
-Alzheimer’s disease, chronic pain, multiple sclerosis and Huntington’s disease are all devastating conditions that don’t have a lot of effective treatments,” said Tsuyuki.
In addition to its partnership with the U of A, Atlas is collaborating with Harvard Medical School in developing cannabis products for pain and other neurological conditions.
A recent study found that medical cannabis is mildly effective in relieving pain and other symptoms in patients with multiple sclerosis (MS).